BIOLIMUS A9
BIOLIMUS A9 性质
| 沸点 | 991.0±75.0 °C(Predicted) |
|---|---|
| 密度 | 1.15±0.1 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | DMF：可溶； DMSO：可溶；乙醇：可溶；甲醇：可溶 |
| 形态 | 固体 |
| 酸度系数(pKa) | 10.40±0.70(Predicted) |
| 颜色 | 白色至浅黄色 |
BIOLIMUS A9 用途与合成方法
Umirolimus is a macrocyclic triene lactone, developed with pharmacological properties specifically tailored for localized drug delivery. Umirolimus can be used drug-eluting stent (DES) applications. Owing to its enhanced lipophilicity,it is strongly attracted to binding sites within the vessel wall and small, tortuous vessels, and contributing to cellular absorption and sustained distribution in the vessel wall surrounding the stent.
Umirolimus prevents progression of the cell cycle in G1 phase by inhibiting IL-2/mTOR-mediated P70-KD S6 protein kinase activation. Umirolimus inhibits T-cell growth, as well as smooth muscle cell growth.
The elimination half-life of Umirolimus is approximately 25 h in whole blood.
BIOLIMUS A9 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-11-08 | HY-122402 | 1 mg | 1363 | ||
| 2024-11-08 | HY-122402 | BIOLIMUS A9 | 851536-75-9 | 5mg | 3000 |
